Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Personalized MedicineMental Disease

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747879

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747879

Personalized Psychiatry

PUBLISHED:
PAGES: 289 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Personalized Psychiatry Market to Reach US$7.5 Billion by 2030

The global market for Personalized Psychiatry estimated at US$4.4 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Personalized Psychiatry Products, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Personalized Psychiatry Services segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 12.6% CAGR

The Personalized Psychiatry market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Personalized Psychiatry Market - Key Trends & Drivers Summarized

How Is the Shift Toward Precision Mental Health Transforming the Practice of Psychiatry?

Personalized psychiatry, also known as precision psychiatry, is redefining the landscape of mental health treatment by leveraging genetic, neurobiological, and environmental data to guide individualized care. Traditional psychiatric treatment has long struggled with variability in drug efficacy, trial-and-error prescriptions, and poorly understood diagnostic boundaries. Personalized psychiatry seeks to overcome these limitations through biomarker-based diagnosis, pharmacogenomic testing, and neuroimaging-guided treatment planning-offering the potential to match the right intervention to the right patient at the right time.

Growing evidence in neuroscience and genomics is enabling more targeted approaches to disorders such as depression, schizophrenia, bipolar disorder, and anxiety. Tools like polygenic risk scores, EEG-based pattern recognition, and machine learning models are increasingly being integrated into psychiatric evaluations. These advancements are improving diagnostic accuracy, reducing adverse drug reactions, and enhancing therapeutic outcomes-particularly in patients with treatment-resistant conditions or comorbidities.

Why Are Pharmacogenomics and Digital Phenotyping Reshaping Psychiatric Intervention Strategies?

Pharmacogenomics has become a cornerstone of personalized psychiatry, offering clinicians actionable insights into how individual genetic profiles influence responses to psychiatric medications. Commercially available gene panels now analyze variations in CYP450 enzymes, serotonin transporters, and other pharmacodynamic targets, guiding the selection and dosing of antidepressants, antipsychotics, and mood stabilizers. This approach minimizes side effects, speeds up therapeutic response, and reduces the burden of trial-based prescribing practices.

Simultaneously, digital phenotyping is gaining traction as a real-time, non-invasive tool for monitoring mood, cognition, and behavior through smartphone sensors, voice analysis, and wearable devices. These technologies generate continuous behavioral data that can detect early signs of relapse, measure treatment response, and support adaptive interventions. Integration of digital biomarkers into clinical workflows is enabling dynamic, data-driven psychiatry that moves beyond episodic consultations toward longitudinal, patient-specific care.

How Are Regulatory Bodies, Reimbursement Systems, and AI Tools Influencing Clinical Adoption?

Regulatory progress is catalyzing market maturity in personalized psychiatry. Agencies such as the FDA and EMA have begun approving pharmacogenomic-based drug labeling and companion diagnostics in psychiatric care. In the U.S., CMS has expanded coverage for select pharmacogenetic tests, while several private insurers are reimbursing validated gene panels in major depressive disorder. These policy developments are encouraging broader clinical uptake and investment in companion diagnostics and AI-powered decision support tools.

AI and machine learning are also facilitating more robust prediction models for mental health conditions, enabling early intervention and stratified risk profiling. These algorithms are being trained on multimodal datasets-including genomics, imaging, EHRs, and wearable outputs-to identify subtypes within traditional diagnostic categories. This nuanced understanding of psychiatric pathophysiology is guiding the development of targeted therapies and supporting the emergence of precision mental health platforms that integrate diagnostics, therapeutics, and patient monitoring in a closed-loop system.

What’s Driving the Global Growth of the Personalized Psychiatry Market?

The growth in the personalized psychiatry market is driven by several factors including the rising prevalence of mental health disorders, growing awareness of interindividual treatment variability, and the convergence of genomics, neuroimaging, and digital health technologies. A primary growth driver is the global shift toward value-based care and outcome-driven reimbursement, which favors precise and effective treatment strategies over broad-spectrum pharmacotherapy.

Expanding access to genomic testing, proliferation of digital health startups, and growing academic-industry collaborations are accelerating the commercialization of personalized psychiatric tools. Moreover, the societal cost of ineffective psychiatric care-reflected in lost productivity, relapse rates, and healthcare expenditures-is incentivizing stakeholders to adopt predictive, personalized treatment models. As research continues to validate biomarkers and refine classification systems, personalized psychiatry is poised to become a foundational component of next-generation mental health care.

SCOPE OF STUDY:

The report analyzes the Personalized Psychiatry market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Products, Services, Software); Therapeutic Area (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Other Therapeutic Areas)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • 23andMe
  • AltheaDx, Inc.
  • Arcara Personalized Psychiatry
  • BrainsWay Ltd.
  • BrightQuest Treatment Centers
  • CBT Plus
  • Genomind
  • GreyBird Ventures
  • HMNC Holding GmbH
  • Karuna Therapeutics
  • Mindstrong
  • Myriad Genetics
  • Peak Mental Wellness
  • Pear Therapeutics
  • Spring Health
  • Starling Minds
  • Sunovion Pharmaceuticals Inc.
  • Tempus AI
  • WayForward
  • Woebot Health

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP35507

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Personalized Psychiatry - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Mental Health Treatments Propels Growth in Personalized Psychiatry Approaches
    • Expansion of Pharmacogenomic Testing Throws the Spotlight on Gene-Drug Interaction Profiling for Psychiatric Care
    • OEM Innovation in AI-Based Behavioral Analysis and Mood Tracking Enhances Tailored Therapy Plans
    • Growth in Use of Wearables and Mobile Apps Supports Continuous Monitoring and Response Optimization
    • OEM Development of Digital Biomarkers and Predictive Analytics Strengthens Early Intervention Capabilities
    • Surging Interest in Psychedelic-Assisted Therapies Fuels Precision-Based Dosing and Patient Matching Strategies
    • OEM Collaboration With Psychiatric Institutions and Genetic Labs Accelerates Research Translation to Clinical Use
    • Increasing Focus on Treatment-Resistant Depression Spurs Demand for Personalized Drug Response Tools
    • OEM Emphasis on Integrated Patient Profiling Across Clinical, Behavioral, and Genomic Data Enhances Decision-Making
    • Expansion of Telepsychiatry and Remote Mental Health Services Supports Digital Personalization Platforms
    • OEM Investment in Longitudinal Mental Health Data Models Enables Predictive Risk Assessment
    • Growth in Direct-to-Consumer Mental Health Diagnostics Encourages Patient Empowerment in Care Decisions
    • OEM Participation in Mental Health AI Consortia Supports Standardization of Algorithms and Clinical Outcomes
    • Surging Need for Adverse Event Prediction in Polypharmacy Cases Drives Use of Predictive Psychiatry Tools
    • OEM Development of Personalized CBT Protocols and AI-Driven Therapy Matching Enhances Efficacy
    • Increasing Payer and Government Support for Value-Based Mental Health Reimbursement Models Fuels Adoption
    • OEM Advances in Voice Analysis, Sleep Monitoring, and Micro-Expression Recognition Expand Non-Invasive Biomarkers
    • Rising Awareness of Comorbid Conditions Strengthens Demand for Integrated Personalized Care Pathways
    • OEM Entry Into Workplace Mental Wellness and Employer-Sponsored Care Programs Supports Commercial Scalability
    • Global Mental Health Burden and Treatment Gaps Propel Investment in Data-Driven, Personalized Psychiatric Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Personalized Psychiatry Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Personalized Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Anxiety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bipolar Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Addiction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Addiction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Addiction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • JAPAN
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • CHINA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • EUROPE
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Personalized Psychiatry by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • FRANCE
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • GERMANY
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Personalized Psychiatry by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • INDIA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Personalized Psychiatry by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Personalized Psychiatry by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • AFRICA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!